|
|Section2= |Section3= }} Etalocib is a drug under development for the treatment of various types of cancer, for example non-small-cell lung carcinoma and pancreatic cancer. It acts as a leukotriene B4 receptor antagonist and a PPARγ agonist. ==References== 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Etalocib」の詳細全文を読む スポンサード リンク
|